Project Details
Description
FT500-101: FT500 as Monotherapy and in Combination with Immune Checkpoint Inhibitors in Subjects with Advanced Solid Tumors
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/18 → 3/1/23 |
Funding
- FATE THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.